(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status

OBJECTIVE: Treating metastatic colorectal cancer with anti-EGFR monoclonal antibodies is recommended only for patients whose tumour does not harbour mutations of KRAS or NRAS. The aim of this study was to investigate the biology of rectal cancers and specifically to evaluate the relationship between...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br J Radiol
Main Authors: Lovinfosse, Pierre, Koopmansch, Benjamin, Lambert, Frederic, Jodogne, Sébastien, Kustermans, Gaelle, Hatt, Mathieu, Visvikis, Dimitris, Seidel, Laurence, Polus, Marc, Albert, Adelin, Delvenne, Philippe, Hustinx, Roland
Formato: Artigo
Idioma:Inglês
Publicado: The British Institute of Radiology. 2016
Assuntos:
Full Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5257332/
https://ncbi.nlm.nih.gov/pubmed/27146067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1259/bjr.20160212
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares